HCWB
HCW Biologics Inc
NASDAQ: HCWB · HEALTHCARE · BIOTECHNOLOGY
$0.47
+15.63% today
Updated 2026-04-30
Market cap
$2.53M
P/E ratio
—
P/S ratio
54.51x
EPS (TTM)
$-10.63
Dividend yield
—
52W range
$0 – $11
Volume
10.9M
WallStSmart proprietary scores
20
out of 100
Grade: F
Strong Sell
Investment rating
2.7
Growth
F5.0
Quality
C+2.5
Profitability
F5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →201 stocks currently score above 75
Price targets
Analyst target
$2.00
+324.45%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-3.36M
- Revenue declining -93.20% QoQ
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $6.72M | $2.84M | $2.57M | $54232.00 | $54230.00 |
| Net income | $-14.90M | $-24.99M | $-30.02M | $-7.96M | $719232.00 |
| EPS | — | — | — | — | $-10.63 |
| Free cash flow | $-20.66M | $-28.72M | $-14.49M | $-13.39M | $-3.36M |
| Profit margin | -221.67% | -879.52% | -1,169.70% | -14,677.14% | — |
Peer comparison
Smart narrative
HCW Biologics Inc trades at $0.47. Our Smart Value Score of 20/100 indicates the stock is weak. TTM revenue stands at $54230.00.
Frequently asked questions
What is HCW Biologics Inc's stock price?
HCW Biologics Inc (HCWB) trades at $0.47.
Is HCW Biologics Inc overvalued?
Smart Value Score 20/100 (Grade F, Strong Sell).
What is the price target of HCW Biologics Inc (HCWB)?
The analyst target price is $2.00, representing +324.4% upside from the current price of $0.47.
What is HCW Biologics Inc's revenue?
TTM revenue is $54230.00.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio54.51x
ROE-27,726.00%
Beta0.91
50D MA$0.51
200D MA$2.47
Shares out0.01B
Float0.01B
Short ratio—
Avg volume10.9M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—